AGMB

#3219
AgomAb Therapeutics NV - ADRs representing one
9.0 9 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
9.05
9.64
Rango anual
7.97
17.82
Cambio diario
+0.11%
Variación mensual
-31.14%
Variación en los últimos 6 meses
-13.59%
Cambio anual
-38.16%
Cierres anteriores
9.0 8
Open
9.1 8
Mínimo
9.0 5
Máximo
9.6 4
Ver el calendario completo

Financials

Visión general Informes Estadísticas Documents

2026

Current report, Q4 FY2026

Agomab Therapeutics NV current report, Q4 FY2026
6-K

Current report, Q3 FY2026

Agomab Therapeutics NV current report, Q3 FY2026
6-K

Current report, Q3 FY2026

Agomab Therapeutics NV current report, Q3 FY2026
6-K

Current report, Q3 FY2026

Agomab Therapeutics NV current report, Q3 FY2026
6-K

Current report, Q3 FY2026

Agomab Therapeutics NV current report, Q3 FY2026
6-K

Current report, Q2 FY2026

Agomab Therapeutics NV current report, Q2 FY2026
6-K

Current report, Q2 FY2026

Agomab Therapeutics NV current report, Q2 FY2026
6-K

Current report, Q2 FY2026

Agomab Therapeutics NV current report, Q2 FY2026
6-K

Current report, Q1 FY2026

Agomab Therapeutics NV current report, Q1 FY2026
6-K

Current report, Q1 FY2026

Agomab Therapeutics NV current report, Q1 FY2026
6-K